Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,849,662 papers from all fields of science
Search
Sign In
Create Free Account
arformoterol
Known as:
(-)-Formoterol
, (R,R)-formoterol
, Formoterol, ((R*,R*)-(+-))-isomer
A long-acting beta-2 adrenergic agonist and isomer of formoterol with bronchodilator activity. Arformoterol selectively binds to and activates beta-2…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Adrenergic beta2-Agonists [MoA]
arformoterol 0.0075 MG/ML Inhalant Solution [Brovana]
Narrower (2)
Arformoterol Tartrate
Brovana
Broader (2)
formoterol
formoterol fumarate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease
C. Loh
,
J. Donohue
,
J. Ohar
Expert Opinion on Drug Safety
2015
Corpus ID: 7767810
Introduction: The global initiative for chronic obstructive lung disease guidelines recommend maintenance therapy using long…
Expand
2014
2014
Arformoterol: rationale for use in chronic obstructive pulmonary disease
J. Terasaki
,
S. Nishi
,
B. Ameredes
,
G. Sharma
2014
Corpus ID: 6660246
Long-acting β-agonists (LABAs) are the standard of care for chronic obstructive pulmonary disease (COPD) patients with advanced…
Expand
2013
2013
Chiral Switch Drugs for Asthma and Allergies: True Benefit or Marketing Hype.
K. Blake
,
H. Raissy
Pediatric Allergy, Immunology, and Pulmonology
2013
Corpus ID: 29729419
Enantiomers are one of several possible molecular configurations present in a drug that has at least 1 chiral center. A drug…
Expand
Review
2012
Review
2012
Ultra-Long-Acting β2-Adrenoceptor Agonists
M. Matera
,
M. Cazzola
Drugs
2012
Corpus ID: 46976912
There has been a real interest recently in developing once-daily β2-adrenoceptor agonists (ultra-long-acting β2-adrenoceptor…
Expand
Review
2012
Review
2012
Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease.
Rachel M. Slaton
,
Danielle L. Cruthirds
P & T : a peer-reviewed journal for formulary…
2012
Corpus ID: 30663138
Chronic obstructive pulmonary disease (COPD) is the collective term for a lower respiratory tract condition that includes chronic…
Expand
2010
2010
Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy.
Xiaolei Zhang
,
Laurie A. Waterman
,
J. Ward
,
J. Baird
,
D. Mahler
Chest
2010
Corpus ID: 40968947
BACKGROUND Walking is a familiar daily activity that is generally limited by breathlessness, whereas cycling is an uncommon…
Expand
2008
2008
Cell Surface Binding, Intracellular cAMP Elevation and Membrane Associated G-Protein Activation by (R,R)- and (S,S)-Formoterols in Androgen Independent Human Prostate Cancer Cell Line, PC3
S. Mitra
2008
Corpus ID: 59426695
The commercially available long acting anti-asthmatic drug, formoterol exists as a racemate of four enantiomers ((R,R)-, (R,S…
Expand
2007
2007
Arformoterol: The first nebulized long-acting beta2-adrenergic agonist
PharmD Bcop Osama Abdelghany
,
P. Merl
2007
Corpus ID: 70697011
Bronchodilators play an important role in the management of stable chronic obstructive pulmonary disease (COPD). Although…
Expand
2004
2004
Enantiomers of beta-agonists exhibit differential effects in combination with dexamethasone on GM-CSF production in human airway smooth muscle cells
B. Ameredes
,
Amber L. Gligonic
,
W. Calhoun
2004
Corpus ID: 70973847
2003
2003
Comparison of bronchodilating and antiinflammatory activities of oral formoterol and its (R,R)-enantiomers.
Q. Xie
,
Ji-qiang Chen
,
W. Shen
,
Qiu-huo Yang
,
R. Bian
Acta Pharmacologica Sinica
2003
Corpus ID: 6233347
AIM To compare the bronchodilating and antiinflammatory effects of oral racemic formoterol (rac-FMT) and (R,R)-formoterol (R,R…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE